Investor & Partner Preview · April 2026

Decoding Skin

A skin intelligence platform built for aesthetics

Glacies Biome helps longevity, wellness, aesthetic, and skincare clinics hyper-personalize care, increase loyalty, and turn every patient journey into measurable outcome data.

Strong commercial traction

Paying customers in the EU and Switzerland with +$1.38M ARR contracts signed; US expansion underway.

B2B platform for personalized skin health

Multi-modal AI links long-read 16S skin microbiome data, facial visual analysis, lifestyle, treatment history, and environment to generate personalized routines, clinic protocols, and longitudinal skin intelligence.

Supported by

Berkeley SkyDeck logo
Fit4Start logo
NVIDIA Inception Program logo
Plug and Play logo

What we're building

Nobody is decoding
the skin. We are.

A molecular-level platform for

aesthetic clinics

built on microbiome science, AI and a proprietary collagen biomarker technology

We save clinicians hours and generate treatment plans and longitudinal outcome data for driving customer royalty.

Microbiome decoding of the skin

A simple swab. Bacterial diversity, barrier function, inflammation markers — clinical-grade molecular biomarkers nobody else in aesthetics has access to.

image

Distinct microbiome clustering across patient profiles

The Skin Microbiome: A Real-Time Sensor for Skin Health

Long-read 16S microbiome data helps Glacies understand how skin is likely to respond across treatments, products, and recovery windows.

Treatment response Barrier strength Aging trajectory Product compatibility Inflammation Collagen quantity

One platform from first scan to measurable outcomes.

For clinics and partners, the same workflow becomes an operating and intelligence layer: patient retention, outcome tracking, product performance, and portfolio decisions in one view.

  • Clinics see conversion, retention, satisfaction, revenue, and follow-up compliance.
  • Partners see anonymized outcome and usage patterns without disrupting clinic workflows.
  • Every measured outcome improves future recommendations and strengthens the data loop.
Glacies Biome workflow 60–69s

Time is now

Why now

The market timing is shifting toward microbiome-led, AI-powered skin intelligence.

Microbiome Mainstreaming

Google searches related to “microbiome skincare” increased over 5,000% [2020–2025]

Multi-modal AI models

Advancement of AI models to solve problems that requires multiple experts from different domains

Obsessed with Longevity & Biomarkers

Sleep, exercise, diet, metabolic health & Now Skin

Our revenue vectors

01 · Plastic Surgery and Aesthetic clinics

Aesthetic Decision Platform

Transforms how clinics diagnose and treat by embedding expert logic into software — unlocking higher patient value through data-driven consultations and treatment paths. Charges as annual subscription.

02 · Dermo-Cosmetics Companies

Treatment-Product Intelligence System

Links treatments, biological signals, and product usage — revealing why certain products perform better and where growth opportunities exist.

Paying customers

image

Competition

Others solve parts. Glacies Biome is built as the full intelligence layer.

Most competitors focus on D2C skincare, brand tools, computer vision, or outsourced biology. Glacies combines clinic distribution, multimodal AI, microbiome depth, outcome data, and brand-agnostic infrastructure in one system.

Business Model Longevity clinics,
skincare professionals
D2C D2C Skincare brands Skincare brands
Data flywheel
& defensibility
Skin Biology / Outsourced
AI / Tech
proficiency
Multimodal Rule based Outsourced Computer Vision Bioinformatics
Brand Agnostic

Team

Scientific, clinical, and commercialization leadership.

Nihat AliyevNihat AliyevCEO & Co-Founder · Bioengineer, University of Luxembourg · Stem cell engineer
Dr. Sarkhan BadirliDr. Sarkhan BadirliCTO & Co-Founder · PhD Computer Vision, Purdue · AI in Drug Discovery, Eli Lilly
Dr. Evan WilliamsDr. Evan WilliamsCSO & Co-Founder · Associate Professor, University of Luxembourg · multi-omics and aging/metabolic disease research
patient clinician MDOmar Haroon MDCMO & Co-Founder · 20+ years in plastic surgery · Founder, Journey of the Face®
Sabine MoraviSabine MoraviBoard Member · Brand Partner B · Novartis

Investment ask

Raising $2M to scale Glacies Biome.

We are raising $2M at an $18M valuation to expand clinic distribution, accelerate product development, and scale the multimodal AI infrastructure behind personalized skin health.

Capital raise $2M
Valuation $18M
Use of funds
  • Clinic expansion across EU, Switzerland, and US entry
  • Product, AI, and microbiome infrastructure
  • Strategic partnerships with skincare and clinic networks

Let's build this together.

Glacies Biome · aliyev@glacies.bio

glacies.bio

Seed round active · backed by Berkeley SkyDeck, NVIDIA Inception, Plug and Play